C. Elegans and Mitochondrial K+ Channels

C. 线虫和线粒体 K 通道

基本信息

  • 批准号:
    8402392
  • 负责人:
  • 金额:
    $ 29.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-01-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Acute myocardial infarction is a leading cause of death throughout the world, while stroke is the third leading cause of death in the United States. Ischemia-reperfusion injury associated with these conditions can lead to permanent tissue damage or neurologic deficits. It is well recognized that non-lethal exposure to ischemia for short periods of time however, elicits a proadaptive response that protects cells from subsequent ischemic injury in a process referred to as preconditioning. Mitochondria are central to the pathogenesis of ischemia- perfusion injury and are believed to be a major target for preconditioning. In particular, ion channels in the inner mitochondrial membrane that transport potassium (KATP and KCa channels) are believed to attenuate the mitochondrial cell death response following preconditioning. The molecular identity of these channels is controversial. The major goal of this proposal is to unambiguously identify the mitochondrial KATP and KCa channels, and a second goal is to identify signaling processes that regulate channel activity in the mitochondria in response to preconditioning. The experiments designed to meet these goals will be carried out in the nematode C. elegans. It has recently been shown that preconditioning can protect this genetic model organism from hypoxic injury and death. Moreover, we have found that C. elegans express functional KATP and KCa channels in their mitochondria. We propose to combine the strengths of two investigators, one with extensive experience in mitochondrial bioenergetics and cardiovascular physiology, and the other in nematode ion channel physiology, to test the hypothesis that KATP and KCa channel regulation is an evolutionarily conserved mechanism that contributes to preconditioning in C. elegans. We will utilize the vast array of genetic resources available in C. elegans to screen strains containing mutations in candidate genes for channel activity in purified mitochondria, for channel regulation via conserved signaling pathways, and for their ability to be preconditioned. The results from these experiments will improve our ability to develop protective therapeutics targeted at channels or upstream regulators and designed to mimic the effects of preconditioning in mammals.
描述(由申请人提供):急性心肌梗死是全世界的主要死因,而卒中是美国的第三大死因。与这些病症相关的缺血再灌注损伤可导致永久性组织损伤或神经功能缺损。然而,众所周知,短时间的非致死性暴露于缺血,在称为预处理的过程中激发了保护细胞免受随后的缺血损伤的前适应性反应。线粒体是缺血-再灌注损伤发病机制的中心,被认为是预处理的主要靶点。特别地,线粒体内膜中转运钾的离子通道(KATP和KCa通道)被认为减弱预处理后的线粒体细胞死亡反应。这些通道的分子身份是有争议的。该提案的主要目标是明确识别线粒体KATP和KCa通道,第二个目标是识别响应于预处理调节线粒体中通道活性的信号传导过程。为实现这些目标而设计的实验将在线虫C中进行。优美的最近的研究表明,预处理可以保护这种遗传模式生物免受缺氧损伤和死亡。此外,我们还发现C.线虫在其线粒体中表达功能性KATP和KCa通道。我们建议结合联合收割机的优势,一个在线粒体生物能量学和心血管生理学方面具有丰富的经验,另一个在线虫离子通道生理学方面具有丰富的经验,以验证KATP和KCa通道调节是一种进化上保守的机制,有助于C.优美的我们将利用C. elegans筛选含有候选基因突变的菌株,用于纯化线粒体中的通道活性,通过保守信号传导途径进行通道调节,以及它们被预处理的能力。这些实验的结果将提高我们开发针对通道或上游调节器的保护性治疗剂的能力,并旨在模拟哺乳动物中的预处理效果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Paul S Brookes其他文献

Nitro-alkenes Confer Cardioprotection and Modify Cys159 of Adenine Nucleotide Translocase in Perfused Heart
  • DOI:
    10.1016/j.freeradbiomed.2010.10.044
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sergiy M Nadtochiy;Paul S Brookes
  • 通讯作者:
    Paul S Brookes
A High-throughput Screen for Molecules that Protect against Ischemia-reperfusion Injury
  • DOI:
    10.1016/j.freeradbiomed.2010.10.007
  • 发表时间:
    2010-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Paul S Brookes
  • 通讯作者:
    Paul S Brookes

Paul S Brookes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Paul S Brookes', 18)}}的其他基金

Mitochondrial K+ Channels as Anti-Obesity Drug Targets
线粒体 K 通道作为抗肥胖药物靶点
  • 批准号:
    10242449
  • 财政年份:
    2020
  • 资助金额:
    $ 29.52万
  • 项目类别:
The Role of the Mitochondrial UPR in Ischemic Protection
线粒体 UPR 在缺血保护中的作用
  • 批准号:
    9223744
  • 财政年份:
    2015
  • 资助金额:
    $ 29.52万
  • 项目类别:
The Role of the Mitochondrial UPR in Ischemic Protection
线粒体 UPR 在缺血保护中的作用
  • 批准号:
    8907809
  • 财政年份:
    2015
  • 资助金额:
    $ 29.52万
  • 项目类别:
The Role of the Mitochondrial UPR in Ischemic Protection
线粒体 UPR 在缺血保护中的作用
  • 批准号:
    9031816
  • 财政年份:
    2015
  • 资助金额:
    $ 29.52万
  • 项目类别:
Mitochondrial K+ Channels and Cardioprotection
线粒体 K 通道和心脏保护
  • 批准号:
    8652105
  • 财政年份:
    2010
  • 资助金额:
    $ 29.52万
  • 项目类别:
Mitochondrial K+ Channels and Cardioprotection
线粒体 K 通道和心脏保护
  • 批准号:
    8788535
  • 财政年份:
    2010
  • 资助金额:
    $ 29.52万
  • 项目类别:
C. Elegans and Mitochondrial K+ Channels
C. 线虫和线粒体 K 通道
  • 批准号:
    7779693
  • 财政年份:
    2010
  • 资助金额:
    $ 29.52万
  • 项目类别:
C. Elegans and Mitochondrial K+ Channels
C. 线虫和线粒体 K 通道
  • 批准号:
    8010191
  • 财政年份:
    2010
  • 资助金额:
    $ 29.52万
  • 项目类别:
C. Elegans and Mitochondrial K+ Channels
C. 线虫和线粒体 K 通道
  • 批准号:
    8575639
  • 财政年份:
    2010
  • 资助金额:
    $ 29.52万
  • 项目类别:
C. Elegans and Mitochondrial K+ Channels
C. 线虫和线粒体 K 通道
  • 批准号:
    8209025
  • 财政年份:
    2010
  • 资助金额:
    $ 29.52万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.52万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了